CLINICAL_TRIALS
trial_result
· 2023-02-08
Clinical Trial Update: Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica [Phase 2]
Summary
Phase 2 trial investigating ruxolitinib cream for cutaneous necrobiosis lipoidica has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aaron R. Mangold | Conditions: Necrobiosis Lipoidica | Phase 2 | Status: COMPLETED | Results posted: 2023-02-08